Canon, Canon Medical and CiRA to commence joint research aimed at realizing high-quality autologous iPS cells

TOKYO, August 1, 2019—Canon Inc. (Headquarters: Ohta-ku, Tokyo, Japan; Chairman & CEO: Fujio Mitarai) Canon Medical Systems Corporation ("Canon Medical"; Headquarters: Tochigi Prefecture, Japan; President: Toshio Takiguchi) and the Center for iPS Cell Research and Application, Kyoto University ("CiRA"; Headquarters: Sakyo-ku, Kyoto, Japan; Director: Shinya Yamanaka) announced today that the parties have agreed to commence joint research from August 1, 2019, with the aim of contributing to the field of regenerative medicine through the realization of higher-quality induced pluripotent stem (iPS) cells¹ for autograft purposes, or "my iPS cells²."

Canon announces award winners for its New Cosmos of Photography 2019 (42nd edition) photo competition

122 listings removed from Amazon.com after Canon files infringement reports

TOKYO, July 29, 2019—Canon Inc. today announced that over approximately one year, it has used Amazon takedown procedures to report infringement based on 122 ASINs, all of which now have been removed from Amazon.com. The ASINs offered third-party laser toner cartridges from 15 vendors, which Canon believes infringe one or more of U.S. Patent No. 8,280,278, U.S. Patent No. 8,630,564, U.S. Patent No. 8,682,215, U.S. Patent No. 8,688,008, U.S. Patent No. 8,676,090 and U.S. Patent No. 8,588,646.